Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Trading Update

9 Feb 2021 07:00

RNS Number : 3816O
Tavistock Investments PLC
09 February 2021
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Trading Update

 

9 February 2021

 

Tavistock Investments Plc, the AIM listed financial services group, is pleased to provide the following trading update for the period ended 31st January 2021.

 

FINANCIAL PERFORMANCE DURING THE PANDEMIC

 

The Company's financial performance during the Coronavirus pandemic has been resilient. The primary impact of the pandemic and associated lockdowns has been a reduction in new Advisory business levels, which are influenced by advisers' ability to meet with clients. However, because the Company benefits from a high level of recurring income, the Board currently expects to report gross revenues for the financial year broadly in line with last year.

 

Prudent management of cost has protected the business and an appropriate structure is now in place to support the Company's future growth. Tavistock has made strong progress with the rationalisation exercise referred to in the Group's interim accounts for the period to 30 September 2020, resulting in the removal of a significant level of cost from the business. Consequently, the Board expects to report EBITDA for the financial year to 31 March 2021, that is significantly ahead of last year.

 

ACQUISITION OF CLIENTS

 

The Company has continued to focus on its growth strategy and recently entered into its tenth client acquisition agreement, using its own cash resources to purchase books of business from advisers who are retiring from the industry. These books of business generate recurring income ranging from £25,000 per annum at the low end, to almost £600,000 at the high end. Ownership of client relationships enables the Company to achieve higher margins from the provision of financial advice.

 

PLATFORM LAUNCH

 

In December 2020, the Company launched the Tavistock Platform, providing a new low-cost platform service to the Company's advisory and investment clients.

 

Entry level charging on the Tavistock Platform is 10 bps regardless of portfolio size. Charges reduce to 5bps and, subsequently 2 bps for high value portfolios. The Board believes that this level of pricing is substantially lower than most competing platforms and this initiative emphasises Tavistock's commitment to providing retail clients with extremely cost-effective solutions to their investment needs. Transitioning clients to the Tavistock Platform will enable the Company to service the entire value chain for retail clients. We believe that it will also increase investment in Tavistock's funds and model portfolios.

 

INVESTMENT PERFORMANCE

 

Following a change of Chief Investment Officer in July 2020, and the introduction of a revised investment strategy, the performance of the Company's funds and model portfolios has seen many of them consistently ranked in the top quartile of the appropriate IA (Investment Association) sector, the key comparator used by advisers across the industry. By way of example, two of our six flagship ACUMEN funds are ranked 1/173 funds, one 3/155 and another 3/141.

 

The combination of strong investment performance and low-cost platform has been very well received by Tavistock's clients - and also by advisers from outside the Company.

 

RECRUITMENT

 

In the past few months, the Company has been successfully recruiting new advisers from a number of well-known competitors including Sandringham, Quilter/Lighthouse and Succession. There is also a growing pipeline of others wishing to join Tavistock either as Appointed Representative firms or Registered Individuals. These additions are expected to make a material contribution to the Company's financial performance in future years.

 

INDUSTRY AWARDS

 

Tavistock has continued to win industry recognition for the high quality of financial advice and investment products that it provides.

 

Tavistock Wealth, the Company's investment management business, has once again been shortlisted as a finalist for a series of awards over the last year, including being runner-up for the Growth Investor Award as Wealth Manager of the Year and a finalist for the Money Marketing Award as Best Discretionary Fund Manager. Its newest fund, the ACUMEN ESG Protection Portfolio, won the Innovation Award at the 2020 Moneyfacts Investment Life & Pension Awards, beating competition from other much larger nominees.

 

Similarly, within the Company's advisory business, Tavistock Private Client has recently won prestigious accolades as Boutique IFA of the Year - England and Most Outstanding & Tax Efficient Investing - England.

 

Brian Raven, Chief Executive, commented: "I am very pleased to update shareholders on so many positive developments, particularly as we approach the end of an extremely challenging financial year. I would like to thank our staff for their dedication and commitment, and I am extremely proud of what we have accomplished together. The Company is now in a strong position to accelerate its growth over the next few years and by so doing, deliver increased value to our shareholders and an enhanced service to our clients."

 

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

 

 

Allenby Capital Limited

(Nominated adviser and broker)

Corporate Finance:

Nick Naylor, Nick Athanas, Liz Kirchner

Sales and Corporate Broking:

Tony Quirke

Tel: 020 3328 5656

 

 

Powerscourt

Gilly Lock

Chloe Retief

 

 

 

Tel: 07711 380 007

020 7250 1446

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLAFSITIIL
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.